Total Payments
$6,071
2024 Payments
$1,028
Companies
41
Transactions
246
Medicare Patients
6,456
Medicare Billing
$552,411
Payment Breakdown by Category
Food & Beverage$5,553 (91.5%)
Education$517.60 (8.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,553 | 239 | 91.5% |
| Education | $517.60 | 7 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,002 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $624.83 | 17 | $0 (2024) |
| UROGEN PHARMA, INC. | $321.52 | 4 | $0 (2021) |
| Endo Pharmaceuticals Inc. | $295.41 | 19 | $0 (2023) |
| ABBVIE INC. | $287.29 | 13 | $0 (2024) |
| PFIZER INC. | $251.73 | 18 | $0 (2024) |
| Axonics, Inc. | $240.13 | 7 | $0 (2023) |
| Teleflex LLC | $224.95 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $223.16 | 10 | $0 (2024) |
| Antares Pharma, Inc. | $213.03 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,028 | 32 | PROCEPT BioRobotics Corporation ($168.72) |
| 2023 | $1,273 | 51 | Janssen Biotech, Inc. ($160.79) |
| 2022 | $893.54 | 41 | Janssen Biotech, Inc. ($210.87) |
| 2021 | $1,163 | 46 | UROGEN PHARMA, INC. ($290.06) |
| 2020 | $375.44 | 18 | Astellas Pharma US Inc ($128.27) |
| 2019 | $433.21 | 19 | Astellas Pharma US Inc ($149.49) |
| 2018 | $422.30 | 25 | Avadel Specialty Pharmaceuticals, LLC ($88.21) |
| 2017 | $481.41 | 14 | Astellas Pharma US Inc ($230.99) |
All Payment Transactions
246 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $168.72 | General |
| Category: UROLOGY | ||||||
| 11/26/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: HORMONE THERAPY | ||||||
| 10/29/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Urology | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $33.07 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Oncology | ||||||
| 07/30/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: HORMONE THERAPY | ||||||
| 06/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $36.74 | General |
| Category: Urology | ||||||
| 06/03/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Oncology | ||||||
| 05/06/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: UROLOGY | ||||||
| 04/30/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 04/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: ONCOLOGY | ||||||
| 04/16/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: ONCOLOGY | ||||||
| 04/09/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: Oncology | ||||||
| 04/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $76.20 | General |
| Category: Oncology | ||||||
| 03/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: ONCOLOGY | ||||||
| 03/02/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: rezum_URO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,492 | 2,055 | $479,020 | $132,443 |
| 2022 | 18 | 1,651 | 2,365 | $527,302 | $150,878 |
| 2021 | 15 | 1,636 | 2,242 | $393,108 | $132,074 |
| 2020 | 18 | 1,677 | 2,160 | $415,715 | $137,016 |
Total Patients
6,456
Total Services
8,822
Medicare Billing
$552,411
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 430 | 561 | $140,820 | $36,337 | 25.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 18 | 174 | $43,500 | $23,441 | 53.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 76 | 96 | $62,400 | $18,555 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 196 | $60,760 | $17,332 | 28.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 91 | 91 | $40,040 | $7,114 | 17.8% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 11 | 11 | $18,700 | $6,217 | 33.2% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 19 | 19 | $18,240 | $6,212 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $18,800 | $4,263 | 22.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 373 | 524 | $31,440 | $4,261 | 13.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $7,080 | $2,090 | 29.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $5,600 | $1,671 | 29.8% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 16 | 16 | $12,080 | $1,309 | 10.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 29 | $6,090 | $1,183 | 19.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 43 | 55 | $9,900 | $1,018 | 10.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 18 | 29 | $1,740 | $816.35 | 46.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 130 | 183 | $1,830 | $624.03 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 425 | 581 | $143,390 | $37,036 | 25.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 19 | 168 | $42,000 | $23,586 | 56.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 184 | 224 | $69,038 | $22,363 | 32.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 83 | 101 | $64,750 | $20,773 | 32.1% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2022 | 18 | 18 | $30,600 | $10,800 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 88 | 88 | $38,370 | $6,940 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $20,814 | $5,922 | 28.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 14 | 15 | $14,400 | $5,104 | 35.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 371 | 544 | $32,600 | $4,456 | 13.7% |
About Dr. Ronald Ebb, MD
Dr. Ronald Ebb, MD is a Urology healthcare provider based in Leominster, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851333546.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Ebb, MD has received a total of $6,071 in payments from pharmaceutical and medical device companies, with $1,028 received in 2024. These payments were reported across 246 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,553).
As a Medicare-enrolled provider, Ebb has provided services to 6,456 Medicare beneficiaries, totaling 8,822 services with total Medicare billing of $552,411. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Leominster, MA
- Active Since 06/10/2006
- Last Updated 02/18/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1851333546
Products in Payments
- ERLEADA (Drug) $600.78
- XTANDI (Drug) $541.75
- Xtandi (Drug) $324.68
- JELMYTO (Drug) $321.52
- XIAFLEX (Biological) $234.27
- XYOSTED (Drug) $197.27
- Axonics (Device) $197.20
- UROLIFT (Device) $182.05
- AQUABEAM SYSTEM (Device) $168.72
- LYNPARZA (Drug) $167.03
- KEYTRUDA (Biological) $150.30
- Natesto (Drug) $149.47
- ORGOVYX (Drug) $131.85
- GEMTESA (Drug) $131.34
- BOTOX (Biological) $103.71
- Nubeqa (Drug) $103.58
- INTERSTIM (Device) $99.53
- UroLift (Device) $95.97
- GENERAL - KIDNEY STONE DISEASE (Device) $89.63
- Noctiva (Drug) $88.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.